TARGETED MOLECULAR IMMUNOTHERAPY Trademark

Trademark Overview

On Wednesday, July 6, 2011, a trademark application was filed for TARGETED MOLECULAR IMMUNOTHERAPY with the United States Patent and Trademark Office. The USPTO has given the TARGETED MOLECULAR IMMUNOTHERAPY trademark a serial number of 85363912. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 17, 2023. This trademark is owned by Globeimmune, Inc.. The TARGETED MOLECULAR IMMUNOTHERAPY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of cancer and infectious disease; therapeutic and prophylactic vaccines
targeted molecular immunotherapy

General Information

Serial Number85363912
Word MarkTARGETED MOLECULAR IMMUNOTHERAPY
Filing DateWednesday, July 6, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 17, 2023
Registration Number4185255
Registration DateTuesday, August 7, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 22, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of cancer and infectious disease; therapeutic and prophylactic vaccines
Disclaimer with Predetermined Text"IMMUNOTHERAPY"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 17, 2023
Primary Code005
First Use Anywhere DateWednesday, February 9, 2005
First Use In Commerce DateWednesday, February 9, 2005

Trademark Owner History

Party NameGlobeimmune, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLouisville, CO 80027
Party NameGlobeimmune, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLouisville, CO 80027
Party NameGlobeimmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLouisville, CO 80027

Trademark Events

Event DateEvent Description
Friday, February 17, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, August 7, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, September 16, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sunday, September 16, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Sunday, September 16, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 14, 2018TEAS SECTION 8 RECEIVED
Monday, August 7, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 7, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, May 22, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 22, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 13, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 12, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 6, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 5, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 5, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 28, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 28, 2012NON-FINAL ACTION E-MAILED
Tuesday, February 28, 2012NON-FINAL ACTION WRITTEN
Wednesday, January 25, 2012PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, January 24, 2012WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, January 10, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 10, 2012ASSIGNED TO LIE
Monday, December 19, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 17, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 16, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 16, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 1, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2011NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2011NON-FINAL ACTION WRITTEN
Tuesday, October 25, 2011ASSIGNED TO EXAMINER
Monday, July 11, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 9, 2011NEW APPLICATION ENTERED

Related Keywords

immunotherapy molecular targeted therapeutic prophylactic vaccines disease infectious preparations treatment cancer pharmaceutical